In 2020, the highest total revenue made by a biopharmaceutical companies specialized in cardiometabolic care worldwide was around 28 billion U.S. dollars by Eli Lilly. This statistic illustrates the total revenue of leading biopharmaceutical companies in cardiometabolic worldwide.
Total revenue of leading biopharmaceutical companies in cardiometabolic care worldwide in 2020*
(in billion U.S. dollars)
* The table lists the most valuable branded players whose
leading product(s) are in the cardiometabolic field.
Major players in diabetes care that are not listed here due to
the strength of other franchise areas include Merck and
Sanofi.
Beyond diabetes care, core drivers in the cardiometabolic
disease area were legacy sales from statins/blood pressure
medications and novel anticoagulants led by Bayer with
Xarelto.
Profit from the additional features of your individual account
Currently, you are using a shared account. To use individual functions (e.g., mark statistics as favourites, set
statistic alerts) please log in with your personal account.
If you are an admin, please authenticate by logging in again.
Learn more about how Statista can support your business.
Torreya Partners. (November 8, 2021). Total revenue of leading biopharmaceutical companies in cardiometabolic care worldwide in 2020* (in billion U.S. dollars) [Graph]. In Statista. Retrieved November 10, 2024, from https://www-statista-com.ezproxy.canberra.edu.au/statistics/1246684/top-biopharma-companies-by-cardiometabolic-revenue-worldwide/
Torreya Partners. "Total revenue of leading biopharmaceutical companies in cardiometabolic care worldwide in 2020* (in billion U.S. dollars)." Chart. November 8, 2021. Statista. Accessed November 10, 2024. https://www-statista-com.ezproxy.canberra.edu.au/statistics/1246684/top-biopharma-companies-by-cardiometabolic-revenue-worldwide/
Torreya Partners. (2021). Total revenue of leading biopharmaceutical companies in cardiometabolic care worldwide in 2020* (in billion U.S. dollars). Statista. Statista Inc.. Accessed: November 10, 2024. https://www-statista-com.ezproxy.canberra.edu.au/statistics/1246684/top-biopharma-companies-by-cardiometabolic-revenue-worldwide/
Torreya Partners. "Total Revenue of Leading Biopharmaceutical Companies in Cardiometabolic Care Worldwide in 2020* (in Billion U.S. Dollars)." Statista, Statista Inc., 8 Nov 2021, https://www-statista-com.ezproxy.canberra.edu.au/statistics/1246684/top-biopharma-companies-by-cardiometabolic-revenue-worldwide/
Torreya Partners, Total revenue of leading biopharmaceutical companies in cardiometabolic care worldwide in 2020* (in billion U.S. dollars) Statista, https://www-statista-com.ezproxy.canberra.edu.au/statistics/1246684/top-biopharma-companies-by-cardiometabolic-revenue-worldwide/ (last visited November 10, 2024)
Total revenue of leading biopharmaceutical companies in cardiometabolic care worldwide in 2020* (in billion U.S. dollars) [Graph], Torreya Partners, November 8, 2021. [Online]. Available: https://www-statista-com.ezproxy.canberra.edu.au/statistics/1246684/top-biopharma-companies-by-cardiometabolic-revenue-worldwide/
